Isu Abxis to supply US$1.6m medicine to Iran's Fara Teb Ayeen
By 황유미Published : June 20, 2016 - 11:40
[DISCLOSURE] Isu Abxis (086890) has signed a 1.9 billion won (US$1.6 million) with Iran’s Fara Teb Ayeen to supply a treatment for Gaucher's disease, it announced on June 20. This amounts to 17.14 percent of its recent revenue.